Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients-Reference-Cited by-同舟云学术

Incidence and Predictive Factors for Infectious Disease after Rituximab Therapy in Kidney-Transplant Patients

Published:2009-07-28 Issue:1 Volume:10 Page:89-98
ISSN:1600-6135
Container-title:American Journal of Transplantation
language:en
Short-container-title:

Author:

Kamar N.,Milioto O.,Puissant-Lubrano B.,Esposito L.,Pierre M. C.,Mohamed A. Ould,Lavayssière L.,Cointault O.,Ribes D.,Cardeau I.,Nogier M. B.,Durand D.,Abbal M.,Blancher A.,Rostaing L.

Publisher

Wiley

Subject

Pharmacology (medical),Transplantation,Immunology and Allergy

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1600-6143.2009.02785.x/fullpdf

Reference44 articles.

1. Rituximab, an anti-cd20 monoclonal antibody: History and mechanism of action;Pescovitz;Am J Transplant,2006

2. The mechanisms of action of rituximab in the elimination of tumor cells;Johnson;Semin Oncol,2003

3. Rituximab: An insider's historical perspective;Grillo-Lopez;Semin Oncol,2000

4. A review of the current use of rituximab in autoimmune diseases;Gurcan;Int Immunopharmacol,2009

5. Clinical effects and safety of rituximab for treatment of refractory pediatric autoimmune diseases;El-Hallak;J Pediatr,2007

Cited by 159 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Outcomes of Kidney Transplantation in Highly HLA-Sensitized Patients Treated with Intravenous Immuno-Globulin, Plasmapheresis and Rituximab: A Meta-Analysis;Life;2024-08-10

2. Outcome of ABO-incompatible Live Donor Renal Transplant: Our Experience in Tertiary Care Center of Northwest India;Journal of Mahatma Gandhi University of Medical Sciences and Technology;2024-04-20

3. Longitudinal analysis of the impact of rituximab on circulating EBV miRNAs in three paediatric kidney transplant recipients;Journal of Clinical Virology Plus;2024-02

4. ABO Incompatible Kidney Transplantation Without B-cell Depletion is Associated With Increased Early Acute Rejection: A Single-Center Australian Experience;Transplant International;2023-09-20

5. Rituximab Toxicity after Preemptive or Therapeutic Administration for Post-Transplant Lymphoproliferative Disorder;Transplantation and Cellular Therapy;2023-01